Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL) belongs to a family of disorders more commonly known as Batten Disease, although it would be a stretch to say that Batten Disease is at all commonly known. It only occurs in about two to four births out of every 100,000 in the United States. Its effects, though, are devastating. In people with CLN2, an aggressive form of Batten Disease that first presents around 2-4 years old, a defective gene inhibits production of a crucial enzyme which allows brain cells to rid themselves of waste. The resulting buildup leads to widespread cell death. Symptoms
To better heal humans on earth, IU researchers need a Zero-G lab.
Could a cure be lying at the bottom of the sea?
A spry 250 years old, Rutgers is still setting the pace for academic institutions.
A rare cancer needs a rare champion.
University of Illinois scientists just figured out how to make a great cancer-fighting drug even better: BTN LiveBIG
Tamoxifen is teaming up with Selinexor to take down breast cancer.
One treatment may reverse even severe symptoms.
Surviving cancer can mean more than beating the disease.
In Iquito, doctors, students, and locals work together for change.